Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Candel Therapeutics, Inc. (CADL)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 28,690,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Candel Therapeutics is a late clinical stage biopharmaceutical company focused on helping patients fight cancer with oncolytic viral immunotherapies. Co. has oncolytic viral immunotherapy platforms based on genetically modified adenovirus and herpes simplex virus constructs. Co.'s product candidate, CAN-2409, is an off-the-shelf adenovirus product candidate combined with the prodrug valacyclovir. Co. is conducting, as part of its CAN-2409 program, a clinical trial in the U.S. for CAN-2409 in patients with newly diagnosed localized prostate cancer who have an intermediate- or high-risk for progression. Co. is also developing its HSV platform product candidates for solid tumor indications.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 128,181
Total Buy Value $0 $0 $0 $242,351
Total People Bought 0 0 0 6
Total Buy Transactions 0 0 0 13
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 46
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Schoch Charles See Remarks   •       –      –    2024-01-12 3 IO $0.00 $0 D/D 0 81,301     -
   Amello Jason Chief Financial Officer   •       –      –    2023-11-28 4 D $0.90 $18,138 D/D (20,153) 202,009     -
   Barone Francesca Chief Scientific Officer   •       –      –    2023-11-28 4 D $0.90 $17,773 D/D (19,748) 186,657     -
   Tak Paul Peter Chief Executive Officer   •       •      –    2023-11-28 4 D $0.90 $39,099 D/D (43,443) 373,556     -
   Nichols Garrett Chief Medical Officer   •       –      –    2023-11-28 4 D $0.90 $10,958 D/D (12,175) 135,126     -
   Tyagarajan Seshu Chief Technology Officer   •       –      –    2023-11-28 4 D $0.90 $15,595 D/D (17,328) 174,230     -
   Tyagarajan Seshu Chief Technology Officer   •       –      –    2023-11-26 4 A $0.00 $0 D/D 104,516 191,558     -
   Nichols Garrett Chief Medical Officer   •       –      –    2023-11-26 4 A $0.00 $0 D/D 88,822 147,301     -
   Amello Jason Chief Financial Officer   •       –      –    2023-11-26 4 A $0.00 $0 D/D 125,717 222,162     -
   Tak Paul Peter Chief Executive Officer   •       •      –    2023-11-26 4 A $0.00 $0 D/D 180,108 416,999     -
   Barone Francesca Chief Scientific Officer   •       –      –    2023-11-26 4 A $0.00 $0 D/D 112,790 206,405     -
   Martell Christopher Director   –       •      –    2022-12-09 4/A B $1.92 $45,984 I/I 23,950 152,000 2.1     -
   Papa Joseph C Director   –       •      –    2022-12-09 4 B $1.94 $67,935 D/D 35,018 38,032 2.39     -
   Tyagarajan Seshu Chief Technology Officer   •       –      –    2022-12-09 4 B $1.93 $19,991 D/D 10,358 13,358 2.74     -
   Martell Christopher Director   –       •      –    2022-12-09 4 B $1.92 $45,984 D/D 23,950 152,000 2.39     -
   Tak Paul Peter Chief Executive Officer   •       •      –    2022-12-09 4 B $1.92 $24,835 D/D 12,935 40,985 2.81     -
   Amello Jason Chief Financial Officer   •       –      –    2022-12-09 4 B $1.93 $4,763 D/D 2,468 5,568 2.66     -
   Martell Christopher Director   –       •      –    2022-12-08 4/A B $1.68 $5,124 I/I 3,050 128,050 2.1     -
   Papa Joseph C Director   –       •      –    2022-12-08 4 B $1.70 $5,124 D/D 3,014 3,014 2.39     -
   Barone Francesca Chief Scientific Officer   •       –      –    2022-12-08 4 B $1.61 $1,993 D/D 1,238 2,738 2.66     -
   Tyagarajan Seshu Chief Technology Officer   •       –      –    2022-12-08 4 B $1.69 $5,070 D/D 3,000 3,000 2.74     -
   Martell Christopher Director   –       •      –    2022-12-08 4 B $1.68 $5,124 D/D 3,050 128,050 2.39     -
   Tak Paul Peter Chief Executive Officer   •       •      –    2022-12-08 4 B $1.70 $5,185 D/D 3,050 28,050 2.81     -
   Amello Jason Chief Financial Officer   •       –      –    2022-12-08 4 B $1.69 $5,239 D/D 3,100 3,100 2.74     -
   Tak Paul Peter Chief Executive Officer   •       •      –    2022-11-28 4 A $0.00 $0 D/D 195,906 220,906     -
  46 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us